Objective: BreastCheck, the Irish Breast Screening Programme, has employed three different models of a full field digital mammography (FFDM) system since its transition to a digital service in 2007. The three models from GE Healthcare, Hologic and Sectra exhibit differences in their design and function, the most significant of which include anode target/filter choice, detector technology and the type of exposure automation. Methods: The aim of this study was to use the results from a clinical breast dose survey to examine the differences between three different FFDM models in terms of exposure selection, breast mean glandular dose (MGD) and automatic exposure control (AEC) dose contribution. Results: The accuracy of the dose estimation was improved by inclusion of the AEC pre-exposure dose contribution. The photon-counting system demonstrated the lowest average MGD. The GE Healthcare and Hologic flat-panel detector systems demonstrated a small but statistically significant dose difference. The pre-exposure dose contribution did not exceed 13% of the total exposure dose for any system in the survey. A comparison of the system calculated organ dose estimate from each machine with the corresponding MGD calculated from medical physics measurements indicated reasonably accurate organ dose estimates for most systems in the survey.
Conclusion:The results of this study provide a comprehensive assessment of the breast dose performance of current digital mammography systems in a clinical screening setting. The nationwide expansion of the Irish breast screening programme in 2007 was accompanied by a transition to full field digital mammography (FFDM) technology. Digital mammography could be still considered as a developing technology and experience with digital mammography in breast screening was limited at the time of the change. The advantages associated with digital imaging with respect to workflow efficiency and productivity are well established while the evidence base for clinical benefit associated with improved breast imaging performance through the adoption of digital imaging for mammography continues to grow [1,2]. There are other emerging advantages of digital imaging in breast screening, including the potential for radiation dose reduction [3][4][5]. Currently available digital mammography systems differ from each other in many ways which can affect the patient dose and can provide system dose advantages. The most significant technical factors in digital mammography systems which impact breast dose include the anode target/filter choice, detector technology and the type of exposure automation. There are also other factors which can affect the dose, including applied breast compression and grid type [6]. A standard feature available on all digital mammography systems is the calculation and display of organ dose estimation. This feature could be a significant factor for the user in the regulation of the patient breast dose.The Irish National Breast Screening Programme, BreastCheck, invites women in the age range 5...